Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Hirotoshi, Iihara"'
Autor:
Hironori Fujii, Akitaka Makiyama, Kayoko Nishimura, Hirotoshi Iihara, Chiemi Hirose, Koichi Ohata, Yunami Yamada, Daichi Watanabe, Itaru Yasufuku, Naoki Okumura, Yoshihiro Tanaka, Takao Takahashi, Ryo Kobayashi, Nobuhisa Matsuhashi, Akio Suzuki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Anamorelin is expected to improve cancer cachexia by increasing lean body mass (LBM) due to increased appetite and protein synthesis. However, the effect of anamorelin on cancer cachexia in real-world practice is unclear. The purp
Externí odkaz:
https://doaj.org/article/ee8816608d5f438b928ba67da044ed10
Autor:
Yunami Yamada, Ryo Kobayashi, Taishi Yamamoto, Hironori Fujii, Hirotoshi Iihara, Kato-Hayashi Hiroko, Shohei Nishida, Ryo Hoshino, Takashi Niwa, Keisuke Kumada, Masahito Shimizu, Akio Suzuki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Medication errors related to the pre-admission medication history obtained on admission are a major cause of medication error during hospitalization. Medication reconciliation (MR) improves patient safety through the detection of
Externí odkaz:
https://doaj.org/article/86df8ec6763f4c95a96f6eb99c7a0894
Autor:
Daichi Watanabe, Hirotoshi Iihara, Ryo Kobayashi, Hironori Fujii, Ryutaro Mori, Keisuke Kumada, Masahito Shimizu, Manabu Futamura, Akio Suzuki
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe effectiveness of a dexamethasone-sparing strategy in the treatment of breast cancer with anthracycline-cyclophosphamide therapy when combined with first-generation 5-HT3 receptor antagonists (RAs) and neurokinin-1 RAs is unclear. This i
Externí odkaz:
https://doaj.org/article/5939a0ab206645f79f0a258203b479fa
Autor:
Daichi Watanabe, Hironori Fujii, Koichi Ohata, Hirotoshi Iihara, Akitaka Makiyama, Ryo Kobayashi, Chiemi Hirose, Shiori Hishida, Serika Matsuoka, Jesse Yu Tajima, Shigeru Kiyama, Takao Takahashi, Akio Suzuki, Nobuhisa Matsuhashi
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Several studies have reported an association between severe neutropenia and long-term survival in patients treated with trifluridine-tipiracil (TAS-102). Because some of these studies failed to address immortality time bias, howev
Externí odkaz:
https://doaj.org/article/cb8ce677d92a4090b254e842a7afaacd
Autor:
Shohei Nishida, Takehiro Kato, Yuichi Hayashi, Shoya Yamada, Hironori Fujii, Michi Yamada, Nao Asai, Shinya Shimizu, Takashi Niwa, Hirotoshi Iihara, Sodai Kubota, Mayu Sakai, Yoshihiro Takahashi, Ken Takao, Masami Mizuno, Takuo Hirota, Ryo Kobayashi, Yukio Horikawa, Daisuke Yabe, Akio Suzuki
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 10, Pp 1202-1208 (2023)
ABSTRACT Aims/Introduction Polypharmacy in diabetes patients is related to worse clinical outcomes. The aim of this study was to evaluate the usefulness of our countermeasure for polypharmacy, which combines a pharmacist check followed by a multidisc
Externí odkaz:
https://doaj.org/article/2c148c80fe2748429a7c3b96da400fa4
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 16, Iss 1, Pp 1-7 (2023)
Abstract Background We previously reported that a standardized pharmacist check of medical orders related to the administration criteria of anticancer drugs prior to preparation of injectable anticancer drugs was useful for reducing drug wastage afte
Externí odkaz:
https://doaj.org/article/621f1b65e2c74141b846da28be1b1fd1
Autor:
Yoshiko Kitazume, Hitoshi Kawazoe, Ryuji Uozumi, Tomoe Yoshizawa, Hirotoshi Iihara, Hironori Fujii, Masaya Takahashi, Takahiro Arai, Yasushi Murachi, Yumiko Sato, Takahiro Mikami, Koji Hashiguchi, Tomoko Yamazaki, Katsuyuki Takahashi, Yukiyoshi Fujita, Yuki Hosokawa, Issei Morozumi, Masami Tsuchiya, Atsushi Yokoyama, Hironobu Hashimoto, Masakazu Yamaguchi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The association between capecitabine efficacy and proton pump inhibitors (PPIs) is controversial. Here, we determined whether co-administration of PPIs affects the real-world effectiveness of capecitabine. This retrospective observational st
Externí odkaz:
https://doaj.org/article/96f14db77f724404b2128c9eb38030de
Autor:
Hironori Fujii, Yukino Ueda, Chiemi Hirose, Koichi Ohata, Kumiko Sekiya, Mika Kitahora, Shiori Sadaka, Senri Yamamoto, Daichi Watanabe, Hiroko Kato-Hayashi, Hirotoshi Iihara, Ryo Kobayashi, Miho Kaburaki, Nobuhisa Matsuhashi, Takao Takahashi, Akitaka Makiyama, Kazuhiro Yoshida, Hideki Hayashi, Akio Suzuki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background The effect of pharmaceutical intervention to treat adverse events on quality of life (QOL) in outpatients receiving cancer chemotherapy is unclear. We investigated whether pharmaceutical intervention provided by pharmacists in col
Externí odkaz:
https://doaj.org/article/3e27ad5d37c74e7f8a5a46f83069ed5b
Autor:
Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe, Kazuki Tanaka, Yukiyoshi Fujita, Masakazu Abe, Hisao Imai, Masato Karayama, Yoh Hayasaki, Chiemi Hirose, Takafumi Suda, Kazuto Nakamura, Akio Suzuki, Yasushi Ohno, Ken-ichirou Morishige, Naoki Inui
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Olanzapine has been reported to be an effective antiemetic in patients receiving carboplatin-based chemotherapy. However, the efficacy of a neurokinin-1 receptor antagonist (NK1RA) added to olanzapine, a 5-hydroxytryptamine-3 rece
Externí odkaz:
https://doaj.org/article/e7f5889a63c04984bd8ab30ae9c8bc6c
Autor:
Hirotoshi Iihara1,2,3 iihara.hirotoshi.p7@f.gifu-u.ac.jp, Mototsugu Shimokawa4,5, Hiroko Bando6, Yoshimi Niwa7, Yutaka Mizuno8, Yoshihiro Kawaguchi9, Mika Kitahora1, Akari Murakami10, Masaaki Kawai11,12, Kazushige Ishida13, Makoto Takeuchi14, Kazuhiro Ishihara15, Tomokazu Iyoda16, Takumi Nakada17, Atsuko Ogiso18, Yasuyuki Kojima19, Fumiyoshi Kumagai20, Aya Sawa21, Ryutaro Mori7, Kosuke Higuchi22
Publikováno v:
Journal of Cancer. 2023, Vol. 14 Issue 14, p2644-2654. 11p.